After having 17 melanoma spots removed, ‘Real Housewives of Beverly Hills’ alum Teddi Mellencamp was diagnosed with multiple ...

opening new avenues to improve the prognosis of patients with advanced cancer. These findings could lead to innovative ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as large as its current approved indication, according to analysts.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

Widely regarded as the most dangerous type of skin cancer, melanoma develops from melanocytes — the cells that give skin its colour. It is formed due to excess exposure to ultraviolet light or ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.